From eggs to avocados – Germany’s Orbem raises €55.5 million for AI-powered MRI expansion

Orbem, a Munich-based DeepTech company, has secured €55.5 million in Series B funding to expand its AI-powered MRI solutions. This investment underscores growing interest in applying AI to improve the efficiency and insights gained from medical imaging and other industrial applications. The company is poised to broaden its reach into the US market and introduce new solutions for the poultry, fruit, and vegetable industries. Orbem's technology utilizes AI to transform Magnetic Resonance Imaging (MRI) and analyze food and biological samples. The company claims it can perform MRI scans in less than one second without human intervention. The funding round was led by Innovation Industries, with contributions from Supernova Invest, General Catalyst, and other existing investors. This development has significant implications for food producers and healthcare providers seeking data-driven decision-making. Orbem's expansion into the US and focus on poultry, fruit, and vegetable quality assessment, alongside potential healthcare applications, could transform several industries. The company's growing biological dataset positions it as a key player in the European DeepTech landscape. The funding round highlights the increasing investment in AI-driven imaging technologies in Europe. Other companies, such as TiHive and Chipiron, have also recently secured funding. Orbem's success suggests a strong investor belief in the scalability of MRI technology and the value of large-scale biological datasets.